earnings
NV
NASDAQ · NVAX
Novavax, Inc.
Healthcare · Biotechnology
$9.21
Down-$0.23 (-2.44%)
Updated Aug 27, 2026, 6:04 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 3.18
- Dividend yield
- 0.00%
- 52-week range
- $7.15 – $11.61
- Volume
- 3.51M
- Avg. volume
- 4.26M
Price performance
NVAX price history
1M range · 21 trading sessions · Daily adjusted prices
NVAX closed at $9.21 after 21 trading sessions, up 25.48% for the selected period.
- Last close
- $9.21
- Period change
- +25.48%
- Period low
- $7.32
- Period high
- $9.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | $9.33 | $9.44 | $9.13 | $9.21 | 3.51M |
| Aug 25, 2026 | $9.07 | $9.58 | $8.93 | $9.44 | 7.11M |
| Aug 24, 2026 | $8.87 | $8.98 | $8.26 | $8.86 | 5.58M |
| Aug 21, 2026 | $8.44 | $9.1995 | $8.435 | $8.94 | 10.45M |
| Aug 20, 2026 | $8.50 | $8.66 | $8.02 | $8.42 | 5.98M |
| Aug 19, 2026 | $8.43 | $8.83 | $8.19 | $8.79 | 11.45M |
| Aug 18, 2026 | $7.97 | $8.08 | $7.835 | $7.93 | 2.02M |
| Aug 17, 2026 | $8.05 | $8.17 | $7.95 | $8.07 | 1.93M |
| Aug 14, 2026 | $8.13 | $8.13 | $7.915 | $8.05 | 2.28M |
| Aug 13, 2026 | $8.01 | $8.23 | $7.92 | $8.14 | 3.51M |
| Aug 12, 2026 | $7.91 | $7.99 | $7.83 | $7.96 | 2.54M |
| Aug 11, 2026 | $7.92 | $8.03 | $7.78 | $7.95 | 2.61M |
| Aug 10, 2026 | $7.892 | $7.96 | $7.695 | $7.89 | 3.23M |
| Aug 7, 2026 | $7.75 | $8.086 | $7.595 | $7.95 | 5.7M |
| Aug 6, 2026 | $7.825 | $7.908 | $7.532 | $7.74 | 4.9M |
| Aug 5, 2026 | $7.71 | $7.755 | $7.54 | $7.70 | 3.63M |
| Aug 4, 2026 | $7.49 | $7.70 | $7.455 | $7.66 | 3.25M |
| Aug 3, 2026 | $7.37 | $7.6099 | $7.26 | $7.41 | 2.58M |
| Jul 31, 2026 | $7.44 | $7.49 | $7.215 | $7.32 | 3.41M |
| Jul 30, 2026 | $7.43 | $7.505 | $7.25 | $7.44 | 2.93M |
| Jul 29, 2026 | $7.29 | $7.465 | $7.235 | $7.34 | 2.33M |
Latest NVAX news
The latest Smart Investors Daily articles mentioning NVAX.
Stock researchCompany · Financials
Loading stock research…